248 related articles for article (PubMed ID: 30094960)
21. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
[TBL] [Abstract][Full Text] [Related]
22. Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology.
Zheng J; Xu W; Liu W; Tang H; Lu J; Yu K; Song X; Li F; Wang Y; Wang R; Chen L; Zhang H; Qiu Y; Wei G; Zhou X; Yang J
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34002799
[TBL] [Abstract][Full Text] [Related]
23. Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis.
Wang Y; Han X; Fu M; Wang J; Song Y; Liu Y; Zhang J; Zhou J; Ge J
J Cell Mol Med; 2018 May; 22(5):2791-2803. PubMed ID: 29502357
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
[TBL] [Abstract][Full Text] [Related]
25. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
[No Abstract] [Full Text] [Related]
26. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic role of EF24 targeting glucose transporter 1-mediated metabolism and metastasis in ovarian cancer cells.
Zhang D; Wang Y; Dong L; Huang Y; Yuan J; Ben W; Yang Y; Ning N; Lu M; Guan Y
Cancer Sci; 2013 Dec; 104(12):1690-6. PubMed ID: 24112101
[TBL] [Abstract][Full Text] [Related]
28. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
[TBL] [Abstract][Full Text] [Related]
29. Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation.
Lu L; Zhang S; Li C; Zhou C; Li D; Liu P; Huang M; Shen X
Cell Death Dis; 2017 May; 8(5):e2767. PubMed ID: 28492557
[TBL] [Abstract][Full Text] [Related]
30. SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells.
Wu Y; Gao WN; Xue YN; Zhang LC; Zhang JJ; Lu SY; Yan XY; Yu HM; Su J; Sun LK
Exp Cell Res; 2018 Jun; 367(2):137-149. PubMed ID: 29580688
[TBL] [Abstract][Full Text] [Related]
31. Cryptotanshinone inhibits lung tumorigenesis and induces apoptosis in cancer cells in vitro and in vivo.
Chen L; Wang HJ; Xie W; Yao Y; Zhang YS; Wang H
Mol Med Rep; 2014 Jun; 9(6):2447-52. PubMed ID: 24682389
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
Tan L; Wang W; He G; Kuick RD; Gossner G; Kueck AS; Wahl H; Opipari AW; Liu JR
Cancer; 2016 Mar; 122(5):722-9. PubMed ID: 26619367
[TBL] [Abstract][Full Text] [Related]
33. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
Wang H; Zhao L; Zhu LT; Wang Y; Pan D; Yao J; You QD; Guo QL
Mol Carcinog; 2014 Feb; 53 Suppl 1():E107-18. PubMed ID: 23761018
[TBL] [Abstract][Full Text] [Related]
34. miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.
Tuo X; Zhou Y; Yang X; Ma S; Liu D; Zhang X; Hou H; Wang R; Li X; Zhao L
Pathol Res Pract; 2022 Sep; 237():154032. PubMed ID: 35914373
[TBL] [Abstract][Full Text] [Related]
35. Inhibiting STAT3 signaling is involved in the anti-melanoma effects of a herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos.
Li T; Fu X; Tse AK; Guo H; Lee KW; Liu B; Su T; Wang X; Yu Z
Sci Rep; 2017 Jun; 7(1):3097. PubMed ID: 28596565
[TBL] [Abstract][Full Text] [Related]
36. SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells.
Cui Y; Qin L; Wu J; Qu X; Hou C; Sun W; Li S; Vaughan AT; Li JJ; Liu J
PLoS One; 2015; 10(6):e0129834. PubMed ID: 26121691
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses.
Han Z; Liu S; Lin H; Trivett AL; Hannifin S; Yang D; Oppenheim JJ
Cancer Immunol Immunother; 2019 Jul; 68(7):1073-1085. PubMed ID: 31161238
[TBL] [Abstract][Full Text] [Related]
38. Cryptotanshinone from the
Nagappan A; Kim JH; Jung DY; Jung MH
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906014
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
40. Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells.
Zhao K; Zhou Y; Qiao C; Ni T; Li Z; Wang X; Guo Q; Lu N; Wei L
J Hematol Oncol; 2015 Apr; 8():41. PubMed ID: 25902914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
